Advertisement

Springer Nature is making Coronavirus research free. View research | View latest news | Sign up for updates

Oral doxycycline outshines IV ceftriaxone in Lyme disease/arthritis

    • 7 Accesses

    This is a preview of subscription content, log in to check access.

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    Oral doxycycline outshines IV ceftriaxone in Lyme disease/arthritis. Pharmacoecon. Outcomes News 124, 7 (1997). https://doi.org/10.1007/BF03271875

    Download citation

    Keywords

    • Ceftriaxone
    • Lyme Disease
    • Radiculopathy
    • Antibacterial Therapy
    • Average Life Expectancy